BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 14663935)

  • 1. [Expression of connective tissue growth factor gene in the hypertrophic scar and keloid tissue].
    Liu JY; Li SR; Ji SX
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2003 Nov; 17(6):436-8. PubMed ID: 14663935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Collagen synthesis and expression of connective tissue growth factor in the cultured fibroblasts of human hypertrophic scar].
    Li SR; Liu JY; Ji SX
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2004 Mar; 20(2):124-7. PubMed ID: 15334937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertrophic scar fibroblasts have increased connective tissue growth factor expression after transforming growth factor-beta stimulation.
    Colwell AS; Phan TT; Kong W; Longaker MT; Lorenz PH
    Plast Reconstr Surg; 2005 Oct; 116(5):1387-90; discussion 1391-2. PubMed ID: 16217483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in TGF-beta 1 and type I, III procollagen gene expression in keloid and hypertrophic scar].
    Tang S; Pang S; Cao Y
    Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1999 Jul; 15(4):283-5. PubMed ID: 11593607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow derived mesenchymal stem cells inhibit the proliferative and profibrotic phenotype of hypertrophic scar fibroblasts and keloid fibroblasts through paracrine signaling.
    Fang F; Huang RL; Zheng Y; Liu M; Huo R
    J Dermatol Sci; 2016 Aug; 83(2):95-105. PubMed ID: 27211019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertrophic scar tissues and fibroblasts produce more transforming growth factor-beta1 mRNA and protein than normal skin and cells.
    Wang R; Ghahary A; Shen Q; Scott PG; Roy K; Tredget EE
    Wound Repair Regen; 2000; 8(2):128-37. PubMed ID: 10810039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The expression of fibrillin 1 in pathologic scars and its significance].
    Nie FF; Wang Q; Qin ZL
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2008 Sep; 24(5):339-42. PubMed ID: 19119630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of mast cell tryptase in scar].
    Gao F; Zhao Y; Feng YQ; Huo R; Xue WJ; Wang FG; Lv RR; Xue F; Li Q; Zhang J
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2010 Mar; 26(2):132-5. PubMed ID: 20540319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of thymosin beta 4 mRNA expression in keloid tissues and fibroblasts cultured from keloid and its significance].
    Nie FF; Wu JQ; Qin ZL
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Feb; 17(2):80-3. PubMed ID: 15698487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-localization of LTBP-2 with FGF-2 in fibrotic human keloid and hypertrophic scar.
    Sideek MA; Teia A; Kopecki Z; Cowin AJ; Gibson MA
    J Mol Histol; 2016 Feb; 47(1):35-45. PubMed ID: 26644005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid, and other fibrotic skin disorders.
    Igarashi A; Nashiro K; Kikuchi K; Sato S; Ihn H; Fujimoto M; Grotendorst GR; Takehara K
    J Invest Dermatol; 1996 Apr; 106(4):729-33. PubMed ID: 8618012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Collagen biosynthesis in normal human skin, normal and hypertrophic scar and keloid.
    Craig RD
    Eur J Clin Invest; 1975 Feb; 5(1):69-74. PubMed ID: 1122925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Change of gene expression of transforming growth factor-beta1, Smad 2 and Smad 3 in hypertrophic scars skins].
    Chen W; Fu X; Sun T; Sun X; Zhao Z; Sheng Z
    Zhonghua Wai Ke Za Zhi; 2002 Jan; 40(1):17-9. PubMed ID: 11955370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of In Vitro Reconstructed Human Normotrophic, Hypertrophic, and Keloid Scar Models.
    Limandjaja GC; van den Broek LJ; Breetveld M; Waaijman T; Monstrey S; de Boer EM; Scheper RJ; Niessen FB; Gibbs S
    Tissue Eng Part C Methods; 2018 Apr; 24(4):242-253. PubMed ID: 29490604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased CCN2 transcription in keloid fibroblasts requires cooperativity between AP-1 and SMAD binding sites.
    Xia W; Kong W; Wang Z; Phan TT; Lim IJ; Longaker MT; Yang GP
    Ann Surg; 2007 Nov; 246(5):886-95. PubMed ID: 17968183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The molecular basis of keloid and hypertrophic scar formation.
    Tuan TL; Nichter LS
    Mol Med Today; 1998 Jan; 4(1):19-24. PubMed ID: 9494966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of the Wnt/beta-catenin pathway induced by transforming growth factor-beta in hypertrophic scars and keloids.
    Sato M
    Acta Derm Venereol; 2006; 86(4):300-7. PubMed ID: 16874413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experimental study of actin and myosin in the scar tissue].
    Zhang Q; Qian YL; Cui L
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2001 Jan; 15(1):32-5. PubMed ID: 12563927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experimental study of Bcl-2 and Fas gene expression in fibroblast of scar].
    Liu Y; Ren LS; Cen Y
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2001 Nov; 15(6):351-3. PubMed ID: 11762221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with different types of scars and keloids.
    Ulrich D; Ulrich F; Unglaub F; Piatkowski A; Pallua N
    J Plast Reconstr Aesthet Surg; 2010 Jun; 63(6):1015-21. PubMed ID: 19464975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.